QR Code

Safety profile following mRNA-1273 COVID-19 primary vaccination in healthy adults in Indonesia

Objectives: To evaluate the safety and benefit-risk profile of mRNA-1273 following the vaccine's authorization and the administration of over one million doses in Indonesia. Design: A retrospective analytical study was conducted to assess adverse events following immunization (AEFI) within 28 days a...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Bernie Endyarni Medise, Nastiti Kaswandani, Nina Dwi Putri, Elcha Leonard, Putra Fajar Angkasa, Ade Putra, Rini Muliasari, Viska Indriani, Prima Yosephine, Julitasari Sundoro, Hindra Irawan Satari, Sri Rezeki Hadinegoro
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Elsevier 2026-06-01
Rangatū:Global Epidemiology
Ngā marau:
Vaccine safety
AEFI
SAE
Urunga tuihono:http://www.sciencedirect.com/science/article/pii/S2590113326000283
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite